Keros Therapeutics, Inc.
KROS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001664710
In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Keros Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 123
- −6 vs. Q1 2023
- Shares held
- 22.4M
- +420.0K (+1.9%) vs. Q1 2023
- Total value
- $901.0M
- −$36.0M (−3.8%) vs. Q1 2023
- New holders
- 14
- 60 more added
- Sold out
- 20
- 27 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KROS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 132 | $198.6M |
| Q1 2026 | 151 | $205.6M |
| Q4 2025 | 166 | $408.4M |
| Q3 2025 | 155 | $558.0M |
| Q2 2025 | 139 | $479.6M |
| Q1 2025 | 156 | $428.6M |
| Q4 2024 | 161 | $582.1M |
| Q3 2024 | 164 | $2.03B |
| Q2 2024 | 152 | $1.44B |
| Q1 2024 | 147 | $2.08B |
| Q4 2023 | 121 | $1.02B |
| Q3 2023 | 107 | $730.6M |
| Q2 2023 | 123 | $901.0M |
| Q1 2023 | 129 | $937.0M |
| Q4 2022 | 126 | $948.2M |
| Q3 2022 | 113 | $680.1M |
| Q2 2022 | 104 | $479.7M |
| Q1 2022 | 106 | $893.0M |
| Q4 2021 | 99 | $944.5M |
| Q3 2021 | 89 | $545.4M |
| Q2 2021 | 80 | $599.7M |
| Q1 2021 | 83 | $887.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Keros Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American Century Companies Inc | 214,003 | $8.60M | 0.01% | +100,860+89.1% | Added |
| Parkman Healthcare Partners LLC | 276,815 | $11.1M | 1.93% | +97,525+54.4% | Added |
| Woodline Partners LP | 279,701 | $11.2M | 0.13% | +81,562+41.2% | Added |
| Clal Insurance Enterprises Holdings Ltd | 299,000 | $12.0M | 0.14% | 00.0% | Unchanged |
| Citadel Advisors LLC | 327,800 | $13.2M | 0.01% | −43,683−11.8% | Reduced |
| Point72 Asset Management, L.P. | 349,660 | $14.0M | 0.05% | +144,000+70.0% | Added |
| Opaleye Management Inc. | 352,650 | $14.2M | 3.39% | +114,650+48.2% | Added |
| CHI Advisors LLC | 402,118 | $16.2M | 4.90% | +141,059+54.0% | Added |
| First Light Asset Management, LLC | 416,830 | $16.7M | 1.31% | −177,134−29.8% | Reduced |
| Geode Capital Management, LLC | 420,722 | $16.9M | 0.00% | +52,676+14.3% | Added |
| Franklin Resources Inc | 472,751 | $19.0M | 0.01% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 497,161 | $20.0M | 2.42% | −245,658−33.1% | Reduced |
| Yiheng Capital Management, L.P. | 554,151 | $22.3M | 1.93% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 580,000 | $23.3M | 0.39% | +280,000+93.3% | Added |
| Candriam Luxembourg S.C.A. | 721,061 | $29.0M | 0.21% | −23,996−3.2% | Reduced |
| State Street Corp | 1,015,903 | $40.8M | 0.00% | +71,744+7.6% | Added |
| Braidwell LP | 1,143,865 | $46.0M | 1.50% | +1,143,865 | New |
| Vanguard Group Inc | 1,183,779 | $47.6M | 0.00% | +135,717+12.9% | Added |
| Price T Rowe Associates Inc | 1,270,361 | $51.0M | 0.01% | +117,845+10.2% | Added |
| OrbiMed Advisors LLC | 1,514,734 | $60.9M | 1.18% | −164,683−9.8% | Reduced |
| Alkeon Capital Management LLC | 1,676,522 | $67.4M | 0.40% | −1,496−0.1% | Reduced |
| BlackRock Inc. | 1,744,397 | $70.1M | 0.00% | +67,137+4.0% | Added |
| FMR LLC | 4,059,041 | $163.1M | 0.01% | +7,168+0.2% | Added |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −930,752−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −77,100−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −67,636−100.0% | Sold out |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −47,304−100.0% | Sold out |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −31,386−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −31,032−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −30,119−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −22,657−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −18,324−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −17,666−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −16,654−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −16,049−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −11,172−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −8,306−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −7,066−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −4,962−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −3,575−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −575−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |